Sensitization Testing
Sensitization testing is a specialized biocompatibility assessment designed to evaluate the potential of a medical device or material to induce allergic reactions in patients or users. For medical devices ranging from wound dressings to implantable sensors, sensitization testing is a mandatory requirement under global regulatory frameworks such as FDA 21 CFR Part 820, EU Medical Device Regulation (MDR 2017/745), and ISO 10993-10. Without robust sensitization data, manufacturers risk regulatory rejection, costly delays, or post-market recalls due to undiscovered allergenic risks.
At Meditronics (a brand of STEMart), we understand that sensitization testing is not merely a checkbox for regulatory submissions—it is a cornerstone of patient safety. Our services help clients identify and mitigate sensitization hazards early in the design phase, ensuring devices meet the highest safety standards while accelerating time-to-market.
Our Service
Sensitization testing methodologies are guided by internationally recognized standards, including ISO 10993-10, OECD Test Guidelines, and FDA Blue Book Memoranda. Meditronics offers both traditional in vivo tests and cutting-edge in vitro alternatives to align with ethical, regulatory, and project-specific needs.
In Vivo Methods
- Guinea Pig Maximization Test (GPMT):
The gold standard for assessing strong sensitizers, GPMT involves intradermal induction and topical challenge phases. It is highly sensitive for detecting low-molecular-weight haptens in devices like polymers or adhesives.
- Buehler Test (Closed-Patch Assay):
A non-adjuvanted method ideal for evaluating topical devices (e.g., patches, creams) under occlusive conditions. It mimics human exposure scenarios with minimal animal stress.
- Murine Local Lymph Node Assay (LLNA):
Recognized by OECD Guideline 429, this quantitative assay measures lymphocyte proliferation in mouse lymph nodes. It reduces animal use by 70% compared to GPMT and provides dose-response data.
In Vitro Methods
- ARE-Nrf2 Luciferase Test:
This OECD-validated assay (Guideline 442D) uses human keratinocytes to measure antioxidant response element (ARE) activation, predicting peptide reactivity and pro-hapten formation.
- Direct Peptide Reactivity Assay (DPRA):
An OECD-approved chemical test (Guideline 442C) analyzing covalent binding between test chemicals and synthetic lysine/cysteine peptides. It is essential for screening leachables in devices with prolonged skin contact.
Meditronics's experts tailor test strategies based on device composition, contact duration (limited vs. permanent), and target patient populations. For instance, implantable cardiovascular devices may require GPMT for comprehensive risk profiling, while wound care products often benefit from LLNA paired with DPRA to align with ISO 10993-23 requirements.
Why Choose Meditronics?
Meditronics stands at the forefront of medical device biocompatibility testing, offering fully accredited sensitization studies that comply with FDA, EU MDR, and ISO standards.
✔ Regulatory Mastery
We ensure your submissions meet FDA's Biological Evaluation Reports (BER) requirements, EU MDR Annex XIV, and China NMPA's GB/T 16886 guidelines. Our reports include detailed risk-benefit analyses and chemical characterization data (per ISO 10993-18).
✔ Customized Testing Strategies
For complex devices (e.g., drug-eluting stents or degradable materials), we integrate sensitization testing with genotoxicity, irritation, and systemic toxicity assessments to build a complete safety profile.
✔ Advanced In Vitro Solutions
As global regulations shift toward animal-free testing, Meditronics's ISO 17025-certified labs offer OECD-validated in vitro assays to satisfy ethical and EU MDR requirements.
✔ Fast Turnaround and Global Support
With laboratories in the US, EU, and Asia, we deliver 24/7 project updates and expedited timelines.
From pre-test consultations to post-study regulatory filings, Meditronics provides end-to-end support to ensure your device's sensitization profile is scientifically defensible and audit-ready. Contact Meditronics today to discuss your sensitization testing needs. Let our team craft a precision testing plan that safeguards patients, satisfies regulators, and propels your product toward successful commercialization.
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Need More Information or Request A Quotation?
Related Links
